Lisa A. Carey

1997–2026 年に発表

別表記
Lisa A Carey
249
論文数
46,810
被引用数
103
h 指数
232
i10 指数

被引用数

Lisa A. Carey の年別被引用数1971 年: 被引用 2 件1994 年: 被引用 2 件1995 年: 被引用 1 件1997 年: 被引用 3 件1998 年: 被引用 3 件1999 年: 被引用 2 件2001 年: 被引用 2 件2002 年: 被引用 5 件2003 年: 被引用 1 件2004 年: 被引用 4 件2005 年: 被引用 12 件2006 年: 被引用 52 件2007 年: 被引用 158 件2008 年: 被引用 238 件2009 年: 被引用 270 件2010 年: 被引用 387 件2011 年: 被引用 377 件2012 年: 被引用 353 件2013 年: 被引用 383 件2014 年: 被引用 364 件2015 年: 被引用 412 件2016 年: 被引用 455 件2017 年: 被引用 397 件2018 年: 被引用 422 件2019 年: 被引用 1,338 件2020 年: 被引用 1,571 件2021 年: 被引用 1,648 件2022 年: 被引用 1,524 件2023 年: 被引用 1,241 件2024 年: 被引用 2,282 件2025 年: 被引用 1,260 件2026 年: 被引用 43 件1972〜1993 年は被引用が無いため表示していません1996 年は被引用が無いため表示していません2000 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 5,262 件、この内訳の 26.7%中国: 引用元論文 2,088 件、この内訳の 10.6%イタリア: 引用元論文 1,069 件、この内訳の 5.4%イギリス: 引用元論文 1,035 件、この内訳の 5.3%ドイツ: 引用元論文 803 件、この内訳の 4.1%フランス: 引用元論文 701 件、この内訳の 3.6%カナダ: 引用元論文 688 件、この内訳の 3.5%スペイン: 引用元論文 680 件、この内訳の 3.4%オーストラリア: 引用元論文 489 件、この内訳の 2.5%オランダ: 引用元論文 452 件、この内訳の 2.3%ベルギー: 引用元論文 451 件、この内訳の 2.3%日本: 引用元論文 442 件、この内訳の 2.2%
0%26.7%その他 28.1%

分野

  • Medicine47.5%
  • Biochemistry, Genetics and Molecular Biology42.9%
  • Immunology and Microbiology2.1%
  • Computer Science1.7%
  • Engineering1.2%
  • Materials Science1%
  • その他3.6%

トピック

  • Breast Cancer Treatment Studies9.9%
  • HER2/EGFR in Cancer Research6.3%
  • Advanced Breast Cancer Therapies3.9%
  • Cancer Cells and Metastasis3.3%
  • Cancer Genomics and Diagnostics3.1%
  • Breast Lesions and Carcinomas2.7%
  • その他70.8%

共著者

全論文

検索で開く
  1. Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2021 被引用: 1,543

  2. Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update

    著者: , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2020 被引用: 1,497

  3. Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Joseph A. Sparano, Tanja Španić, Sandra M. Swain, Sergei Tjulandin, Masakazu Toi, Dario Trapani, Andrew Tutt, B. Xu, Giuseppe Curigliano, Nadia Harbeck - Annals of Oncology 2023 被引用: 844

  4. Triple negative breast cancer: Pitfalls and progress

    著者: , - npj Breast Cancer 2022 被引用: 766

  5. Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline

    著者: , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2021 被引用: 998

  6. Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Viviana Galimberti, Hebatallah Gamal El Din Mohamed Mahmoud, Judy E. Garber, Michael Gnant, William J. Gradishar, Bahadır M. Güllüoğlu, Nadia Harbeck, Chiun‐Sheng Huang, Jens Huober, André Ilbawi, Zefei Jiang, Steven Johnston, Eun Sook Lee, Sibylle Loibl, Monica Morrow, Ann H. Partridge, Martine Piccart, Philip Poortmans, Aleix Prat, Meredith M. Regan, Isabella Rubio, Hope S. Rugo, Emiel J. Rutgers, Felix Sedlmayer, Vladimir Semiglazov, Hans-Joerg Senn, Zhiming Shao, Tanja Španić, Petra Tesařová, Beat Thürlimann, Sergei Tjulandin, Masakazu Toi, Maureen Trudeau, Nicholas Turner, Inez Vaz Luis, Giuseppe Viale, Toru Watanabe, William P. Weber, Eric P. Winer, Binghe Xu - Annals of Oncology 2021 被引用: 803

  7. Asparagine bioavailability governs metastasis in a model of breast cancer

    著者: , , , , , , , , , , , , , , , , , , , , - Nature 2018 被引用: 554

  8. Biomarker analyses in the phase III ASCENT study of sacituzumab govitecan versus chemotherapy in patients with metastatic triple-negative breast cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - Annals of Oncology 2021 被引用: 299

  9. Intracranial Efficacy and Survival With Tucatinib Plus Trastuzumab and Capecitabine for Previously Treated HER2-Positive Breast Cancer With Brain Metastases in the HER2CLIMB Trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2020 被引用: 549

  10. Race, Breast Cancer Subtypes, and Survival in the Carolina Breast Cancer Study

    著者: , , , , , , , , , , , , , , , , - JAMA 2006 被引用: 3,834

  11. openalex_id:w4226348827

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Simon Read, Ewan Straiton, R. Jakesz, Christian Fesl, Olivia Pagani, Richard D. Gelber, Michelino De Laurentiis, Sabino De Placido, Ciro Gallo, Kathy S. Albain, Stewart Anderson, R. Arriagada, John M.S. Bartlett, Elizabeth Bergsten-Nordström, Judith M. Bliss, Étienne Brain, Lisa A. Carey, Robert E. Coleman, Jack Cuzick, Nancy Davidson, Lucia Del Mastro, Angelo Di Leo, James Dignam, Mitch Dowsett, Bent Ejlertsen, Matthew Goetz, Pam Goodwin, Pat Halpin-murphy, Dan Hayes, Catherine Hill, Reshma Jagsi, Wolfgang Janni, Sibylle Loibl, Eleftherios P Mamounas, Miguel Martín, Hirofumi Mukai, Valentina Nekljudova, Larry Norton, Yasuo Ohashi, Lori Pierce, Philip Poortmans, Kathleen I Pritchard, Vinod Raina, Daniel Rea, John Robertson, Emiel Rutgers, Tanja Spanic, Joseph Sparano, Guenther Steger, Gong Tang, Masakazu Toi, Andrew Tutt, Giuseppe Viale, Xiang Wang, Tim Whelan, Nicholas Wilcken, Norman Wolmark, David Cameron, Jonas Bergh, Sandra M Swain 被引用: 223

  12. The Triple Negative Paradox: Primary Tumor Chemosensitivity of Breast Cancer Subtypes

    著者: , , , , , , , , , - Clinical Cancer Research 2007 被引用: 2,118

  13. TBCRC 048: Phase II Study of Olaparib for Metastatic Breast Cancer and Mutations in Homologous Recombination-Related Genes

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2020 被引用: 500

  14. Impact of the Addition of Carboplatin and/or Bevacizumab to Neoadjuvant Once-per-Week Paclitaxel Followed by Dose-Dense Doxorubicin and Cyclophosphamide on Pathologic Complete Response Rates in Stage II to III Triple-Negative Breast Cancer: CALGB 40603 (Alliance)

    著者: , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2014 被引用: 1,030

  15. De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Chiun‐Sheng Huang, Jens Huober, Hussein Khaled, Jacek Jassem, Zefei Jiang, Per Karlsson, Monica Morrow, Roberto Orecchia, Kent C. Osborne, Olivia Pagani, Ann H. Partridge, K. Pritchard, Jungsil Ro, Emiel J. Rutgers, Felix Sedlmayer, Semiglazov Vf, Zhi‐Ming Shao, Ian Smith, Masakazu Toi, Andrew Tutt, Giuseppe Viale, Toru Watanabe, Timothy J. Whelan, Binghe Xu - Annals of Oncology 2017 被引用: 1,255

  16. Tucatinib vs Placebo, Both in Combination With Trastuzumab and Capecitabine, for Previously Treated ERBB2 (HER2)-Positive Metastatic Breast Cancer in Patients With Brain Metastases

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - JAMA Oncology 2022 被引用: 197

  17. Final Results From the Randomized Phase III ASCENT Clinical Trial in Metastatic Triple-Negative Breast Cancer and Association of Outcomes by Human Epidermal Growth Factor Receptor 2 and Trophoblast Cell Surface Antigen 2 Expression

    著者: , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2024 被引用: 153

  18. Tucatinib versus placebo added to trastuzumab and capecitabine for patients with pretreated HER2+ metastatic breast cancer with and without brain metastases (HER2CLIMB): final overall survival analysis

    著者: , , , , , , , , , , , , , , , , , , , - Annals of Oncology 2021 被引用: 210

  19. Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer: final 10-year analysis of the open-label, single-arm, phase 2 APT trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2023 被引用: 165

  20. Estrogen and Progesterone Receptor Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Guideline Update

    著者: , , , , , , , , , , , , , , , , , , , - Archives of Pathology & Laboratory Medicine 2020 被引用: 369

  21. Radiotherapy to regional nodes in early breast cancer: an individual patient data meta-analysis of 14 324 women in 16 trials

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jon Godwin, Sam James, Amanda Kerr, Hui Liu, Elizabeth MacKinnon, Gurdeep Mannu, Theresa McHugh, Philip Morris, Mariko Nakahara, Simon Read, Hannah Taylor, John Ferguson, H Scheurlen, Stefano Zurrida, Viviana Galimberti, James N. Ingle, Pinuccia Valagussa, Umberto Veronesi, Stewart Anderson, Gong Tang, Bernard Fisher, Sophie D. Fosså, Kristin V. Reinertsen, Herman Høst, Hyman B. Muss, Kaija Holli, Kathy S. Albain, R. Arriagada, John M.S. Bartlett, Elizabeth Bergsten-Nordström, Judith M. Bliss, Étienne Brain, Lisa A. Carey, Robert E. Coleman, Jack Cuzick, Nancy E. Davidson, Lucia Del Mastro, Angelo Di Leo, James J. Dignam, Mitch Dowsett, Bent Ejlertsen, Prue Francis, José Á. García-Sáenz, Rich Gelber, Michael Gnant, Matthew P. Goetz, Pam Goodwin, Pat Halpin-Murphy, Dan Hayes, Catherine Hill, Reshma Jagsi, Wolfgang Janni, Sibylle Loibl, Eleftherios P. Mamounas, Miguel Martín, Stuart McIntosh, Hirofumi Mukai, Valentina Nekljudova, Larry Norton, Yasuo Ohashi, Martine Piccart, Lori J. Pierce, Vinod Raina, Daniel Rea, Meredith M. Regan, J.F.R. Robertson, Emiel J. Rutgers, Roberto Salgado, Dennis J. Slamon, Tanja Španić ほか 14 名 - The Lancet 2023 被引用: 151

  22. CALGB 40603 (Alliance): Long-Term Outcomes and Genomic Correlates of Response and Survival After Neoadjuvant Chemotherapy With or Without Carboplatin and Bevacizumab in Triple-Negative Breast Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , William M. Sikov - Journal of Clinical Oncology 2022 被引用: 151

  23. Multiomics in primary and metastatic breast tumors from the AURORA US network finds microenvironment and epigenetic drivers of metastasis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Julie M. Gastier‐Foster, Mothaffar F. Rimawi, Rita Nanda, Nancy U. Lin, Claudine Isaacs, P. Kelly Marcom, Anna Maria Storniolo, Fergus J. Couch, Uma Chandran, Michael A. Davis, Jonathan C. Silverstein, Alexander J. Ropelewski, Minetta C. Liu, Susan G. Hilsenbeck, Larry Norton, Andrea L. Richardson, W. Fraser Symmans, Antonio C. Wolff, Nancy E. Davidson, Lisa A. Carey, Adrian V. Lee, Justin M. Balko, Katherine A. Hoadley, Peter W. Laird, Elaine R. Mardis, Tari A. King, AURORA US Network, Aguirre A. de Cubas, Charles M. Perou - Nature Cancer 2022 被引用: 114

  24. Safety analyses from the phase 3 ASCENT trial of sacituzumab govitecan in metastatic triple-negative breast cancer

    著者: , , , , , , , , , , , , , , , , , - npj Breast Cancer 2022 被引用: 103